Quotient Technology Inc (QUOT) Stock Fundamental Analysis

NYSE:QUOT • US7491191034

3.99 USD
0 (0%)
At close: Sep 1, 2023
3.99 USD
0 (0%)
After Hours: 9/1/2023, 8:04:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

QUOT gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 92 industry peers in the Media industry. QUOT has a bad profitability rating. Also its financial health evaluation is rather negative. QUOT is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • QUOT had negative earnings in the past year.
  • QUOT had a positive operating cash flow in the past year.
QUOT Yearly Net Income VS EBIT VS OCF VS FCFQUOT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 0 20M -20M 40M -40M -60M

1.2 Ratios

  • QUOT has negative profitability rations, so we won't be analyzing them here.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
QUOT Yearly ROA, ROE, ROICQUOT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 -10 -20 -30 -40

1.3 Margins

  • QUOT's Gross Margin of 49.75% is fine compared to the rest of the industry. QUOT outperforms 64.95% of its industry peers.
  • QUOT's Gross Margin has declined in the last couple of years.
  • The Profit Margin and Operating Margin are not available for QUOT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 49.75%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.43%
GM growth 5Y-3.81%
QUOT Yearly Profit, Operating, Gross MarginsQUOT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 0 20 -20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • QUOT does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, QUOT has more shares outstanding
  • The debt/assets ratio for QUOT has been reduced compared to a year ago.
QUOT Yearly Shares OutstandingQUOT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M
QUOT Yearly Total Debt VS Total AssetsQUOT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 200M 400M 600M

2.2 Solvency

  • QUOT has an Altman-Z score of -0.44. This is a bad value and indicates that QUOT is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of -0.44, QUOT is not doing good in the industry: 78.35% of the companies in the same industry are doing better.
  • A Debt/Equity ratio of 0.30 indicates that QUOT is not too dependend on debt financing.
  • The Debt to Equity ratio of QUOT (0.30) is better than 69.07% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF N/A
Altman-Z -0.44
ROIC/WACCN/A
WACC8.13%
QUOT Yearly LT Debt VS Equity VS FCFQUOT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 0 100M 200M 300M

2.3 Liquidity

  • QUOT has a Current Ratio of 1.37. This is a normal value and indicates that QUOT is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.37, QUOT is doing worse than 60.82% of the companies in the same industry.
  • A Quick Ratio of 1.37 indicates that QUOT should not have too much problems paying its short term obligations.
  • The Quick ratio of QUOT (1.37) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.37
Quick Ratio 1.37
QUOT Yearly Current Assets VS Current LiabilitesQUOT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • QUOT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 47.44%, which is quite impressive.
  • QUOT shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -38.13%.
  • QUOT shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -2.16% yearly.
EPS 1Y (TTM)47.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%64.44%
Revenue 1Y (TTM)-38.13%
Revenue growth 3Y-12.85%
Revenue growth 5Y-2.16%
Sales Q2Q%-5.12%

3.2 Future

  • Based on estimates for the next years, QUOT will show a very strong growth in Earnings Per Share. The EPS will grow by 29.32% on average per year.
  • The Revenue is expected to grow by 2.18% on average over the next years.
EPS Next Y75%
EPS Next 2Y42.74%
EPS Next 3Y29.32%
EPS Next 5YN/A
Revenue Next Year-6.16%
Revenue Next 2Y0.48%
Revenue Next 3Y2.18%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
QUOT Yearly Revenue VS EstimatesQUOT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M
QUOT Yearly EPS VS EstimatesQUOT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -0.2 -0.4 -0.6 -0.8

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for QUOT. In the last year negative earnings were reported.
  • The Price/Forward Earnings ratio is 130.39, which means the current valuation is very expensive for QUOT.
  • Based on the Price/Forward Earnings ratio, QUOT is valued a bit more expensive than the industry average as 69.07% of the companies are valued more cheaply.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 27.96, QUOT is valued quite expensively.
Industry RankSector Rank
PE N/A
Fwd PE 130.39
QUOT Price Earnings VS Forward Price EarningsQUOT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
QUOT Per share dataQUOT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2

4.3 Compensation for Growth

  • QUOT's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • QUOT's earnings are expected to grow with 29.32% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y42.74%
EPS Next 3Y29.32%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for QUOT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

Quotient Technology Inc

NYSE:QUOT (9/1/2023, 8:04:00 PM)

After market: 3.99 0 (0%)

3.99

0 (0%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)08-08
Earnings (Next)11-06
Inst Owners0%
Inst Owner Change0%
Ins Owners7.64%
Ins Owner Change0%
Market Cap397.92M
Revenue(TTM)266.03M
Net Income(TTM)-40.42M
Analysts45.71
Price Target4.08 (2.26%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-133.79%
Min EPS beat(2)-171.49%
Max EPS beat(2)-96.08%
EPS beat(4)0
Avg EPS beat(4)-179.71%
Min EPS beat(4)-271.57%
Max EPS beat(4)-96.08%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-5.04%
Min Revenue beat(2)-6.87%
Max Revenue beat(2)-3.21%
Revenue beat(4)0
Avg Revenue beat(4)-8.73%
Min Revenue beat(4)-17.12%
Max Revenue beat(4)-3.21%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)10.09%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-344.44%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.58%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 130.39
P/S 1.5
P/FCF N/A
P/OCF 73.77
P/B 2.56
P/tB 16.14
EV/EBITDA N/A
EPS(TTM)-0.41
EYN/A
EPS(NY)0.03
Fwd EY0.77%
FCF(TTM)-0.16
FCFYN/A
OCF(TTM)0.05
OCFY1.36%
SpS2.67
BVpS1.56
TBVpS0.25
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 49.75%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.43%
GM growth 5Y-3.81%
F-Score4
Asset Turnover0.82
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 118.69%
Cap/Sales 7.92%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.37
Quick Ratio 1.37
Altman-Z -0.44
F-Score4
WACC8.13%
ROIC/WACCN/A
Cap/Depr(3y)63.54%
Cap/Depr(5y)74.54%
Cap/Sales(3y)4.05%
Cap/Sales(5y)4.9%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)47.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%64.44%
EPS Next Y75%
EPS Next 2Y42.74%
EPS Next 3Y29.32%
EPS Next 5YN/A
Revenue 1Y (TTM)-38.13%
Revenue growth 3Y-12.85%
Revenue growth 5Y-2.16%
Sales Q2Q%-5.12%
Revenue Next Year-6.16%
Revenue Next 2Y0.48%
Revenue Next 3Y2.18%
Revenue Next 5YN/A
EBIT growth 1Y30.45%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year214.87%
EBIT Next 3Y58.55%
EBIT Next 5YN/A
FCF growth 1Y-168.52%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-85%
OCF growth 3YN/A
OCF growth 5YN/A

Quotient Technology Inc / QUOT FAQ

Can you provide the ChartMill fundamental rating for Quotient Technology Inc?

ChartMill assigns a fundamental rating of 2 / 10 to QUOT.


What is the valuation status of Quotient Technology Inc (QUOT) stock?

ChartMill assigns a valuation rating of 1 / 10 to Quotient Technology Inc (QUOT). This can be considered as Overvalued.


Can you provide the profitability details for Quotient Technology Inc?

Quotient Technology Inc (QUOT) has a profitability rating of 1 / 10.


Can you provide the financial health for QUOT stock?

The financial health rating of Quotient Technology Inc (QUOT) is 3 / 10.